Y. van der Graaf

5.5k total citations
84 papers, 3.9k citations indexed

About

Y. van der Graaf is a scholar working on Surgery, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Y. van der Graaf has authored 84 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 18 papers in Epidemiology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Y. van der Graaf's work include Cerebrovascular and Carotid Artery Diseases (9 papers), Peripheral Neuropathies and Disorders (6 papers) and Cardiac Imaging and Diagnostics (6 papers). Y. van der Graaf is often cited by papers focused on Cerebrovascular and Carotid Artery Diseases (9 papers), Peripheral Neuropathies and Disorders (6 papers) and Cardiac Imaging and Diagnostics (6 papers). Y. van der Graaf collaborates with scholars based in Netherlands, United States and Germany. Y. van der Graaf's co-authors include Yvonne T. van der Schouw, J.D. Banga, Ewout W. Steyerberg, Marinus J.C. Eijkemans, Nicolette C. Notermans, John H. J. Wokke, Harrie‐Jan Hendricks Franssen, R A de Melker, F.G.I. Jennekens and A.I.M. Bartelds and has published in prestigious journals such as New England Journal of Medicine, The Lancet and American Journal of Psychiatry.

In The Last Decade

Y. van der Graaf

80 papers receiving 3.7k citations

Peers

Countries citing papers authored by Y. van der Graaf

Since Specialization

Citations

This map shows the geographic impact of Y. van der Graaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. van der Graaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. van der Graaf more than expected).

Fields of papers citing papers by Y. van der Graaf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. van der Graaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. van der Graaf. The network helps show where Y. van der Graaf may publish in the future.

Co-authorship network of co-authors of Y. van der Graaf

This figure shows the co-authorship network connecting the top 25 collaborators of Y. van der Graaf. A scholar is included among the top collaborators of Y. van der Graaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. van der Graaf. Y. van der Graaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	114Estimating individual cardiovascular disease risk reduction by blood pressure lowering in elderly patients: results from the HYVET study 2018 ·European Heart Journal ·Tamar I. de Vries, Ruth Peters, Nigel Beckett, Jannick A N Dorresteijn, Jan Westerink, Mariëlle H. Emmelot‐Vonk, Majon Muller, Y. van der Graaf, C J Bulpitt, Frank L.J. Visseren	1
2	Chronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study 2017 ·Journal of Thrombosis and Haemostasis ·Gürbey Ocak, Maarten B. Rookmaaker, Ale Algra, Gert J. de Borst, Pieter A. Doevendans, L. Jaap Kappelle, Marianne C. Verhaar, Frank L.J. Visseren, Y. van der Graaf, Diederick E. Grobbee, Guy E.H.M. Rutten, Tim Leiner, Hendrik M. Nathoe	76
3	Personalized cardiovascular disease prevention by applying individualized prediction of treatment effects 2014 ·European Heart Journal ·Joep van der Leeuw, Paul M. Ridker, Y. van der Graaf, Frank L.J. Visseren	45
4	Unrecognised myocardial infarction in subjects at high vascular risk: prevalence and determinants 2009 ·Heart ·Matthijs F.L. Meijs, Michiel L. Bots, Maarten J. Cramer, (unknown), Birgitta K. Velthuis, Y. van der Graaf, Frank L.J. Visseren, W P Mali, Pieter A. Doevendans, (unknown)	8
5	Rationale and design of the SMART Heart study 2007 ·Netherlands Heart Journal ·Matthijs F.L. Meijs, Michiel L. Bots, (unknown), (unknown), Paul G. Melman, Birgitta K. Velthuis, Y. van der Graaf, (unknown), Pieter A. Doevendans	11
6	Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: the SMART study 2006 ·European Heart Journal ·J. Marc C. van Dijk, Y. van der Graaf, M. L. Bots, Diederick E. Grobbee, A. Algra, (unknown)	66
7	Chest radiography and pneumonia in primary care: diagnostic yield and consequences for patient management 2006 ·European Respiratory Journal ·(unknown), Arno W. Hoes, Y. van der Graaf, Sandra Kalmijn, A. P. E. Sachs, W.P.T.M. Mali	27
8	Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke 2005 ·Journal of Thrombosis and Haemostasis ·Arjen J. C. Slooter, Frits R. Rosendaal, Bea C. Tanis, Jeanet M. Kemmeren, Y. van der Graaf, Ale Algra	83
9	Screening for asymptomatic internal carotid artery stenosis and aneurysm of the abdominal aorta: comparing the yield between patients with manifest atherosclerosis and patients with risk factors for atherosclerosis only1 1Competition of interest: none. 2003 ·Journal of Vascular Surgery ·H. A. J. M. Kurvers, Y. van der Graaf, Jan D. Blankensteijn, Frank L.J. Visseren, B.C. Eikelboom	54
10	Oral contraceptives and the risk of myocardial infarction. Reply 2002 ·New England Journal of Medicine ·FR Rosendaal, (unknown), Y. van der Graaf	0
11	Laparoscopic or conventional Nissen fundoplication for gastrooesophageal reflux disease: randomised clinical trial 2000 ·The Lancet ·J. E. Bais, (unknown), (unknown), MA Cuesta, (unknown), E. C. Klinkenberg‐Knol, JJB van Lanschot, J. H. S. M. Nadorp, A. J. P. M. Smout, Y. van der Graaf, (unknown)	200
12	Osteogenesis imperfecta in childhood: Impairment and disability—A follow-up study 1999 ·Archives of Physical Medicine and Rehabilitation ·Raoul Engelbert, Frits A. Beemer, Y. van der Graaf, Paul J.M. Helders	34
13	Towards a better diagnosis of throat infections (with group A beta-haemolytic streptococcus) in general practice. 1998 ·PubMed ·(unknown), M L Bartelink, Y. van der Graaf, Wil H. F. Goessens, R A de Melker	52
14	Distribution of muscle weakness of central and peripheral origin 1998 ·Journal of Neurology Neurosurgery & Psychiatry ·Roland D. Thijs, Nicolette C. Notermans, John H. J. Wokke, Y. van der Graaf, J van Gijn	12
15	A randomized comparison of physical performance following laparoscopic and open inguinal hernia repair. The Coala Trial Group. 1997 ·PubMed ·Mike S.L. Liem, Y. van der Graaf, (unknown), (unknown), (unknown)	48
16	Osteogenesis Imperfecta in Childhood: Impairment and Disability 1997 ·PEDIATRICS ·Raoul Engelbert, Y. van der Graaf, R. van Empelen, F. A. Beemer, P. J. M. Helders	52
17	Menopause and cardiovascular disease 1997 ·Journal of Psychosomatic Obstetrics & Gynecology ·Y. van der Graaf, Miriam J.J. de Kleijn, Yvonne T. van der Schouw	29
18	Psychosocial intervention following suicide attempt: a svstematic review of treatment interventions 1997 ·Acta Psychiatrica Scandinavica ·Rob van der Sande, Erik Buskens, E. Allart, Y. van der Graaf, Hermán van Engeland	64
19	Chronic idiopathic axonal polyneuropathy: a five year follow up. 1994 ·Journal of Neurology Neurosurgery & Psychiatry ·N. C. Notermans, John H. J. Wokke, Y. van der Graaf, Harrie‐Jan Hendricks Franssen, Gert W. van Dijk, F.G.I. Jennekens	82
20	THE PREVALENCE OF CEREBRAL VISUAL DISTURBANCE IN CHILDREN WITH CEREBRAL PALSY 1992 ·Developmental Medicine & Child Neurology ·(unknown), Onno van Nieuwenhuizen, Y. van der Graaf, D. Wittebol‐Post, J. Willemse	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact